Technology-based support program for Asian American caregivers of Alzheimer's patients

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates a technology-based information and coaching program designed specifically for Asian American midlife women who are family caregivers for individuals living with Alzheimer's disease. The program aims to improve health outcomes for these caregivers and their care recipients. Participants will be randomly assigned to either the intervention group, which will use the TACAD program, or a control group that will not use the program. The study will involve 60 self-reported Asian American women aged 40 to 65 who meet specific criteria, including language proficiency and internet access.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* self reported Asian American midlife women who are family caregivers of persons living with Alzheimer's disease (AACA).
* Participants will be included if, by self-report, they are Asian American women aged 40 to 65 years old who identify as Chinese or Korean;
* are family caregivers of PLAD;
* can read and write English, Mandarin Chinese or Korean;
* who reside in the U.S.;
* have access to the Internet through computers or mobile devices.
* Participants must be providing at least 4 hours per day unpaid assistance, on average, for a community-dwelling person in the early-middle stage of illness (Clinical Dementia Rating of 1) for whom there is no plan for institutionalization in six months.
* Caregivers may or may not reside with their care recipient.

Exclusion Criteria:

* Those who used the AA website previously and/or participated in other studies related to AD will be excluded.

Where it's running

• University of Texas at Austin
  Austin, Texas, United States Recruiting

Study contacts

• Principal investigator: Eun-Ok Im, PhD, MPH — University of Texas at Austin
• Study coordinator: Wonshik Chee, PhD
• Email: tacad.help@austin.utexas.edu
• Phone: 512-232-2323

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Blood biomarker cohort for memory disorders in older adults

  This observational cohort will collect blood samples and brain imaging data from adults 50+ with memory disorders and a small group of healthy young adults to help find biomarkers.

  Recruiting Yonsei University · Seoul, Seodamun-gu · NCT07880275

• Tau changes after hip or knee replacement surgery

  Researchers will see if brain tau changes after hip or knee surgery and whether these changes relate to inflammation and thinking abilities.

  Recruiting Uppsala University Hospital · Uppsala · NCT07871487

• Low-Dose Whole-Brain Radiation Therapy With HeLaXON 1X in Mild Alzheimer's Dementia

  This study will test whether a low-dose brain radiation treatment using HeLaXON helps people with mild Alzheimer's dementia improve or stabilize thinking and daily function.

  Recruiting ReadyCure Inc. · Cheonan, Chungcheongnam-do · NCT07863011

• Cervical lymphatic surgery to see if it helps people with mild Alzheimer’s

  We’re testing a surgical approach in people with mild Alzheimer’s to see if creating alternative neck lymph drainage routes can affect brain biomarkers and daily function.

  Recruiting at 2 sites Maliszewski Daniel · Gdansk and 1 other locations · NCT07857759

• Transcranial random noise stimulation for behavioral and psychological symptoms in Alzheimer's disease

  This trial tests whether high-frequency transcranial random noise stimulation can help people with early Alzheimer's disease who have BPSD, compared to a sham treatment.

  Recruiting Anhui Medical University · Hefei, Anhui · NCT07827196

• Testing LY4405094 in healthy people and people with Alzheimer’s disease

  This study tests LY4405094 to see if it is safe and how it behaves in the body, including how it reaches the brain fluid in healthy participants and how it affects a brain protein in people with Alzheimer's disease.

  Recruiting Phase 1 Eli Lilly and Company · Anaheim, California and 17 other locations · NCT07787182

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.